Literature DB >> 14998612

Chronologic distribution of stroke after minimally invasive versus conventional coronary artery bypass.

Garrett K Peel1, Sotiris C Stamou, Mercedes K C Dullum, Peter C Hill, Kathleen A Jablonski, Ammar S Bafi, Steven W Boyce, Kathleen R Petro, Paul J Corso.   

Abstract

OBJECTIVES: We sought to investigate whether the chronologic distribution of the onset of stroke occurring after coronary artery bypass graft surgery (CABG) without cardiopulmonary bypass (off-pump CABG) is different from the conventional on-pump approach (CABG with cardiopulmonary bypass).
BACKGROUND: Off-pump CABG has been associated with a lower stroke rate, compared with conventional on-pump CABG. However, it is unknown whether the chronologic distribution of the onset of stroke is different between the two approaches.
METHODS: We evaluated the chronologic distribution of postoperative stroke in patients undergoing CABG from June 1996 to August 2001 (n = 10,573). Preoperative risk factors for stroke were identified using the Northern New England preoperative estimate of stroke risk. Multivariate logistic regression analysis was used to determine the independent predictors of early stroke and to delineate the association between the surgical approach and the chronologic distribution of the onset of stroke.
RESULTS: Stroke occurred in 217 patients (2%, n = 10,573). A total of 44 (20%) and 173 (80%) of these patients had stroke after off-pump CABG and on-pump CABG, respectively. The median time for the onset of stroke was two days (range 0 to 11 days) after on-pump CABG versus four days (range 0 to 14 days) after off-pump CABG (p < 0.01). On-pump CABG was associated with a higher risk of early stroke (odds ratio 5.3, 95% confidence interval 2.6 to 10.9; p < 0.01) compared with off-pump CABG.
CONCLUSIONS: Compared with off-pump CABG, on-pump CABG is associated with an earlier onset of postoperative stroke during the recovery phase, suggesting different mechanisms in the pathogenesis of stroke between the two surgical approaches.

Entities:  

Mesh:

Year:  2004        PMID: 14998612     DOI: 10.1016/j.jacc.2003.09.047

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  Platelet Counts and Postoperative Stroke After Coronary Artery Bypass Grafting Surgery.

Authors:  Jörn A Karhausen; Alan M Smeltz; Igor Akushevich; Mary Cooter; Mihai V Podgoreanu; Mark Stafford-Smith; Susan M Martinelli; Manuel L Fontes; Miklos D Kertai
Journal:  Anesth Analg       Date:  2017-10       Impact factor: 5.108

2.  Off-pump coronary artery bypass grafting with an aortic nonclamping technique may reduce the incidence of cerebral complications.

Authors:  Hiroshi Osawa; Hirotaka Inaba; Osamu Kinoshita; Okihiko Akashi; Sachito Minegishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-10-08

3.  Two-staged treatment strategy in patients with severe carotid or cerebrovascular diseases undergoing coronary artery bypass grafting.

Authors:  Yuki Okamoto; Kenji Minakata; Tomoyuki Yunoki; Masatake Katsu; Shin-Ichiro Chino; Masahiko Matsumoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-11-15

4.  Antithrombotic therapy in cardiac embolism.

Authors:  Alvaro Cervera; Angel Chamorro
Journal:  Curr Cardiol Rev       Date:  2010-08

5.  Antithrombotic medication for cardioembolic stroke prevention.

Authors:  M Àngels Font; Jerzy Krupinski; Adrià Arboix
Journal:  Stroke Res Treat       Date:  2011-06-22

6.  Risk factors for recurrent stroke after coronary artery bypass grafting.

Authors:  Li Cao; Qin Li; Qi Bi; Qin-Jun Yu
Journal:  J Cardiothorac Surg       Date:  2011-11-23       Impact factor: 1.637

7.  Early Versus Delayed Stroke After Cardiac Surgery: A Systematic Review and Meta-Analysis.

Authors:  Mario Gaudino; Mohammed Rahouma; Michele Di Mauro; Bobby Yanagawa; Ahmed Abouarab; Michelle Demetres; Antonino Di Franco; Mohammed J Arisha; Dina A Ibrahim; Massimo Baudo; Leonard N Girardi; Stephen Fremes
Journal:  J Am Heart Assoc       Date:  2019-06-19       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.